1-2 of 2
Linda Elder
Close
Sort by
Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD
Journal: Blood
Blood (2016) 128 (22): 4669.
https://doi.org/10.1182/blood.V128.22.4669.4669
Published: 2016
Journal Articles

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

Rupa Narayan, MD, Jonathan Benjamin, MD PhD, Ginna Laport, MD, Lu Tian, PhD, Keri Tate, PhD, Linda Elder, Leah Galvez, RN, Randall Armstrong, Kevin Sheehan, PhD, Robert Lowsky, MD, Sally Arai, MD, Laura Johnston, MD, David Miklos, MD PhD, Lori S. Muffly, MD, Andrew R. Rezvani, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Samuel Strober, MD, Robert Negrin, MD, Everett Meyer, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3232.
https://doi.org/10.1182/blood.V126.23.3232.3232
Published: 2015